Healthcare provider profile · identity verified

Richard Hock, MD

Internal Medicine · NASHVILLE, TN · NPI 1891887212

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	851	230
Atorvastatin Calcium	Atorvastatin Calcium	833	221
Amlodipine Besylate	Amlodipine Besylate	752	206
Rosuvastatin Calcium	Rosuvastatin Calcium	585	185
Omeprazole	Omeprazole	506	158
Levothyroxine Sodium	Levothyroxine Sodium	412	114
Ozempic	Semaglutide	355	50
Lisinopril	Lisinopril	315	83
Gabapentin	Gabapentin	313	80
Zolpidem Tartrate	Zolpidem Tartrate	271	42
Mounjaro	Tirzepatide	266	41
Tamsulosin Hcl	Tamsulosin Hcl	252	69
Duloxetine Hcl	Duloxetine Hcl	244	66
Metformin Hcl	Metformin Hcl	241	64
Simvastatin	Simvastatin	231	66
Jardiance	Empagliflozin	225	48
Metoprolol Succinate	Metoprolol Succinate	221	65
Trazodone Hcl	Trazodone Hcl	220	73
Pantoprazole Sodium	Pantoprazole Sodium	202	54
Fluticasone Propionate	Fluticasone Propionate	195	80
Hydrochlorothiazide	Hydrochlorothiazide	179	57
Eliquis	Apixaban	175	46
Ezetimibe	Ezetimibe	168	48
Escitalopram Oxalate	Escitalopram Oxalate	159	48
Alprazolam	Alprazolam	149	28
Sertraline Hcl	Sertraline Hcl	149	45
Allopurinol	Allopurinol	147	41
Meloxicam	Meloxicam	146	43
Carvedilol	Carvedilol	130	35
Pravastatin Sodium	Pravastatin Sodium	128	35
Synthroid	Levothyroxine Sodium	121	33
Albuterol Sulfate Hfa	Albuterol Sulfate	114	61
Tramadol Hcl	Tramadol Hcl	104	21
Finasteride	Finasteride	103	30
Chlorthalidone	Chlorthalidone	100	33
Mirtazapine	Mirtazapine	96	28
Furosemide	Furosemide	92	34
Azelastine Hcl	Azelastine Hcl	88	34
Glimepiride	Glimepiride	81	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	79	21
Irbesartan	Irbesartan	79	22
Montelukast Sodium	Montelukast Sodium	78	22
Potassium Chloride	Potassium Chloride	76	22
Metformin Hcl Er	Metformin Hcl	75	23
Pregabalin	Pregabalin	75	17
Atenolol	Atenolol	70	22
Esomeprazole Magnesium	Esomeprazole Magnesium	67	16
Xarelto	Rivaroxaban	67	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	63	17
Alendronate Sodium	Alendronate Sodium	60	20
Clopidogrel	Clopidogrel Bisulfate	59	15
Myrbetriq	Mirabegron	59	12
Metoprolol Tartrate	Metoprolol Tartrate	58	18
Nifedipine Er	Nifedipine	57	17
Olmesartan Medoxomil	Olmesartan Medoxomil	57	15
Warfarin Sodium	Warfarin Sodium	56	14
Valsartan	Valsartan	55	18
Bupropion Xl	Bupropion Hcl	53	14
Famotidine	Famotidine	51	17
Venlafaxine Hcl Er	Venlafaxine Hcl	50	11
Clonazepam	Clonazepam	48	suppressed
Valacyclovir	Valacyclovir Hcl	47	14
Febuxostat	Febuxostat	46	suppressed
Donepezil Hcl	Donepezil Hcl	45	11
Ramipril	Ramipril	45	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	42	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	42	12
Tizanidine Hcl	Tizanidine Hcl	42	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	32
Wegovy	Semaglutide	41	suppressed
Citalopram Hbr	Citalopram Hydrobromide	40	11
Prednisone	Prednisone	39	15
Enalapril Maleate	Enalapril Maleate	38	suppressed
Spironolactone	Spironolactone	38	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	35	23
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	28
Ropinirole Hcl	Ropinirole Hcl	35	11
Lovastatin	Lovastatin	34	11
Celecoxib	Celecoxib	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	16
Lansoprazole	Lansoprazole	33	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	18
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Benazepril Hcl	Benazepril Hcl	30	suppressed
Torsemide	Torsemide	29	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Repatha Sureclick	Evolocumab	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	24	24
Terazosin Hcl	Terazosin Hcl	24	suppressed
Azithromycin	Azithromycin	23	20
Levetiracetam	Levetiracetam	23	suppressed
Methylprednisolone	Methylprednisolone	23	19
Buspirone Hcl	Buspirone Hcl	22	suppressed
Estradiol	Estradiol	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Topiramate	Topiramate	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	11
Verapamil Er	Verapamil Hcl	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	11
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Gemtesa	Vibegron	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Levofloxacin	Levofloxacin	16	13
Memantine Hcl	Memantine Hcl	16	suppressed
Naltrexone Hcl	Naltrexone Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Linzess	Linaclotide	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Temazepam	Temazepam	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Diazepam	Diazepam	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Alprazolam Er	Alprazolam	13	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Glipizide	Glipizide	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Bromfenac Sodium	Bromfenac Sodium	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Betaxolol Hcl	Betaxolol Hcl	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Lagevrio (Eua)	Molnupiravir	11	11
Oxycontin	Oxycodone Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error